Lexicon Pharmaceuticals LXRX Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- Lexicon Pharmaceuticals (LXRX) reported increase (decrease) in prepaid expense and other assets of $319K in Q1 2026.
- How has Lexicon Pharmaceuticals's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Lexicon Pharmaceuticals's increase (decrease) in prepaid expense and other assets increased by 126.3% year-over-year, from -$1.21M to $319K.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks the change in payments made in advance for goods or services that will be consumed in future periods. It reflects the company's commitment of cash for upcoming operational needs such as insurance, rent, or research contracts. Significant changes can indicate shifts in operational scale or timing of major expenditures.